Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 4, 2003, Pages 564-572

  Sewell, Diane L ^a   Reinke, Emily K ^a   Co, Dominic O ^a   Hogan, Laura H ^a   Fritz, Robert B ^b   Sandor, Matyas ^a   Fabry, Zsuzsa ^a,c  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BCG VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BCG VACCINATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GRANULOMA; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; T LYMPHOCYTE; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; TH1 CELLS; TUBERCULOMA; TUBERCULOSIS;

EID: 0038105562     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.4.564-572.2003     Document Type: Article

References (44)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Andersen, E., H. Isager, and K. Hyllested. 1981. Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol. Scand. 63:131-135.
4. Ben-Nun, A., I. Mendel, G. Sappler, and N. Kerlero de Rosbo. 1995. A 12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J. Immunol. 154:2939-2948.
5. Ben-Nun, A., and S. Yossefi. 1992. Staphylococcal enterotoxin B as a potent suppressant of T lymphocytes; trace levels suppress T lymphocyte proliferative responses. Eur. J. Immunol. 22:1495-1503.
6. Ben-Nun, A., S. Yossefi, and D. Lehmann. 1993. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Eur. J. Immunol. 23:689-696.
7. Birnbaum, G., L Kotilinek, S. D. Miller, C. S. Raine, Y. L. Gao, P. V. Lehmann, and R. S. Gupta. 1998. Heat shock proteins and experimental autoimmune encephalomyelitis. II. Environmental infection and extraneuraxial inflammation alter the course of chronic relapsing encephalomy elitis. J. Neuroimmunol. 90:149-161.
8. Classen, J. B., and D. C. Classen. 1999. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity 31:43-45.
9. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournie. 1994. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267-270.
10. Coutinho, A., and W. Haas. 2001. In vivo models of dominant T-cell tolerance: where do we stand today? Trends Immunol. 22:350-351.
11. Diaz-Bardales, B. M., S. M. Novaski, A. E. Goes, G. M. Castro, J. Mengel, and L. M. Santos. 2001. Modulation of the severity of experimental autoimmune encephalomyelitis by gammadelta T lymphocytes activated by mycobacterial antigens. Immunol. Investig. 30:245-258.
12. Feige, U., A. Schulmeister, J. Mollenhauer, K. Brune, and H. Bang. 1994. A constitutive 65 kDa chondrocyte protein as a target antigen in adjuvant arthritis in Lewis rats. Autoimmunity 17:233-239.
13. Feige, U., and W. van Eden. 1996. Infection, autoimmunity and autoimmune disease. Experientia Supplementum 77:359-373.
14. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
15. Gao, Y. L., C. F. Brosnan, and C. S. Raine. 1995. Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J. Immunol. 154:3548-3556.
16. Gazda, L.S., A. G. Baxter, and K. J. Lafferty. 1996. Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol. Cell Biol. 74:401-407.
17. Grabie, N., I. Wohl, S. Youssef, G. Wildbaum, and N. Karin. 1999. Expansion of neonatal tolerance to self in adult life. I. The role of a bacterial adjuvant in tolerance spread. Int. Immunol. 11:899-906.
18. Hogan, L. H., W. Markofski, A. Bock, B. Barger, J. D. Morrissey, and M. Sandor. 2001. Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect. Immun. 69:2596-2603.
19. Hunter, S. F., and D. A. Hafler. 2000. Ubiquitous pathogens: links between infection and autoimmunity in MS? Neurology 55:164-165.
20. Kim, J. Y., S. H. Cho, Y. W. Kim, E. C. Jang, S. Y. Park, E. J. Kim, and S. K. Lee. 1999. Effects of BCG, lymphotoxin and bee venom on insulitis and development of IDDM in non-obese diabetic mice. J. Korean Med. Sci. 14:648-652.
21. Kohm, A. P., P. A. Carpentier, H. A. Anger, and S. D. Miller. 2002. Cutting edge: CD4(+)CD25(+) regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712-4716.
22. Lehmann, D., and A. Ben-Nun. 1992. Bacterial agents protect against autoimmune disease, I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J. Autoimmun. 5:675-690.
23. Martins, T. C., and A. P. Aguas. 1999. Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells. Clin. Exp. Immunol. 115:248-254.
24. Metwali, A., D. Elliott, A. M. Blum, J. Li, M. Sandor, R. Lynch, N. Noben-Trauth, and J. V. Weinstock. 1996. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:4546-4553.
25. Muller, D., P. Pakpreo, J. Filla, K. Pederson, F. Cigel, and V. Malkovska. 1995. Increased gamma-delta T-lymphocyte response to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice. Infect. Immun. 63:2361-2366.
26. Orme, I. M., and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis, Immunol. Today 20:307-312.
27. Papiernik, M. 2001. Natural CD4+ CD25+ regulatory T cells. Their role in the control of superantigen responses. Immunol. Rev. 182:180-189.
28. Pinto, M., M. Torten, and S. C. Birnbaum. 1978. Suppression of the in vivo humoral and cellular immune response by staphylococcal enterotoxin B (SEB). Transplantation 25:320-323.
29. Qin, H. Y., J. F. Elliott, J. R. Lakey, R. V. Rajotte, and B. Singh. 1998. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. J. Autoimmun. 11:591-601.
30. Qiu, B., K. A. Frait, F. Reich, E. Komuniecki, and S. W. Chensue. 2001. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am. J. Pathol. 158:1503-1515.
31. Regner, M., and P. H. Lambert. 2001. Autoimmunity through infection of immunization? Nat. Immunol. 2:185-188.
32. Rhoades, E. R., A. M. Cooper, and I. M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63:3871-3877.
33. Ristori, G., M. G. Buzzi, U. Sabatini, E. Giugni, S. Bastianello, F. Viselli, C. Buttinelli, S. Ruggieri, C. Colonnese, C. Pozzilli, and M. Salvetti. 1999. Use of Bacille Calmette-Guerin (BCG) in multiple sclerosis. Neurology 53:1588-1589.
34. Rook, G. A., G. Ristori, M. Salvetti, G. Giovannoni, E. J. Thompson, and J. L. Stanford. 2000. Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders. Immunol. Today. 21:503-508.
35. Selmaj, K., C. F. Brosnan, and C. S. Raine. 1991. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc. Natl. Acad. Sci. USA 88:6452-6456.
36. Sewell, D. L., E. K. Reinke, L. H. Hogan, M. Sandor, and Z. Fabry. 2002. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett. 82:101-110.
37. Shehadeh, N., F. Calcinaro, B. J. Bradley, I. Bruchlim, P. Vardi, and K. J. Lafferty. 1994. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707.
38. Silveira, P. A., and A. G. Baxter. 2001. The NOD mouse as a model of SLE. Autoimmunity 34:53-64.
39. Stauffer, Y., S. Marguerat, F. Meylan, C. Ucla, N. Sutkowski, B. Huber, T. Pelet, and B. Conrad. 2001. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 15:591-601.
40. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302.
41. van Crevel, R., T. H. Ottenhoff, and J. W. van der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15:294-309.
42. a.World Health Organization. 2002. Global tuberculosis control: surveillance, planning, financing. WHO Report 2002. WHO/CDS/TB/2002.295.
43. Wucherpfennig, K. W. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Investig. 108:1097-1104.
44. Zhao, M. L., and R. B. Fritz. 1998. Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and alpha/beta T cell-deficient C57BL/6 mice. J. Neuroimmunol. 87:171-178.